Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...
NICE's endorsement of olaparib, produced by AstraZeneca, marks a crucial step forward in the treatment of breast cancer. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback